Technology area: Biotechnology & Pharmaceuticals
329 pending office actions • 169 clients • 297 examiners • 167 art units • 0 of 329 (0%) have an AI response strategy ready
MORRISON & FOERSTER LLP has 335 pending office actions in Biotechnology & Pharmaceuticals and 24044 career applications. Its resolved allowance rate is 78.42%, and the average is 3.43 office actions per allowance.
The profile reflects a large current docket and an extensive career application record. The allowance rate describes resolved outcomes, while the office-action average indicates the examination activity associated with allowances.
For practitioners, these figures support assessment of a substantial biotechnology and pharmaceutical prosecution practice across workload, historical outcomes, and examination interaction. Aggregate measures do not show how technology, claim scope, or prosecution strategy affected individual results.
Based on the USPTO statutory response window for each pending office action. 102 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 102 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 8 (2%) |
| §101 + other | 47 (14%) |
| §103 only | 91 (28%) |
| §102 only | 10 (3%) |
| §112 only | 34 (10%) |
| Double-patenting only | 3 (1%) |
| Double-patenting + other | 34 (10%) |
| Multi-statute (no §101) | 96 (29%) |
| No statute on record | 6 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAGE, BRENT T | 3 | 82.4% | +10.7% |
| RAHMANI, NILOOFAR | 3 | 77.6% | -2.9% |
| RAHMAN, MASUDUR | 3 | 72.9% | +31.7% |
| CHATTERJEE, JAYANTA | 3 | 44.0% | +70.1% |
| YAMASAKI, ROBERT J | 3 | 67.4% | +44.1% |
| LULTSCHIK, WILLIAM G | 2 | 22.5% | +31.6% |
| STEPHENS, REBECCA JOHANNA | 2 | 68.2% | +27.7% |
| SHEN, YANXIN NMN | 2 | 84.6% | +26.4% |
| BELL, SARA ELIZABETH | 2 | 68.8% | +38.2% |
| VARADARAJ, ARCHANA | 2 | 80.0% | +33.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18972633 | SOYBEAN VARIETIES | PAGE, BRENT T | — |
| 18972620 | SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' | PAGE, BRENT T | — |
| 18832867 | MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN | VARADARAJ, ARCHANA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17798824 | METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA | BERKE-SCHLESSEL, DAVID W | 259d overdue |
| 17941369 | SYSTEMS AND METHODS FOR ONBOARDING AND SUPPORTING CREDIT PRODUCT PARTNERS | GREGG, MARY M | 167d overdue |
| 18368303 | ADAPTIVE SELECTION OF STIMULI FOR NEURO-ACTIVATION | SAHAND, SANA | 164d overdue |
| 19055495 | MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT | LARGI, MATTHEW THOMAS | 126d overdue |
| 17428591 | ORAL FORMULATIONS OF A BIOLOGICALLY ACTIVE PEPTIDE AND USES THEREOF | PEEBLES, KATHERINE | 124d overdue |
| 18357613 | SYSTEMS AND METHODS FOR HUMAN-MACHINE PARTNERED PTSD PREDICTION | EDWARDS, PHILIP CHARLES | 98d overdue |
| 18174000 | INTELLIGENT SYSTEMATIC AGENT: AN ENSEMBLE OF DEEP LEARNING AND EVOLUTIONARY STRATEGIES | SUSSMAN MOSS, JACOB ZACHARY | 66d overdue |
| 17796563 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | WHITEMAN, BRIAN A | 58d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18541719 | SYNTHETIC ACTIVATION OF MULTIMERIC TRANSMEMBRANE RECEPTORS | CHATTERJEE, JAYANTA | 26d overdue |
| 18298998 | METHODS OF SCREENING FOR PLANT GAIN OF FUNCTION MUTATIONS AND COMPOSITIONS THEREFOR | CHATTERJEE, JAYANTA | 22d overdue |
| 18575208 | METHOD FOR EDITING BANANA GENES | CHATTERJEE, JAYANTA | 11d overdue |
| 17599446 | EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS | RAHMAN, MASUDUR | 7d |
| 18516616 | VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY | YAMASAKI, ROBERT J | 8d |
| 17629322 | Increasing Long-Sequence Yields In Template-Free Enzymatic Synthesis of Polynucleotides | YAMASAKI, ROBERT J | 27d |
| 19231374 | DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY | LULTSCHIK, WILLIAM G | 62d |
| 19215928 | SOYBEAN VARIETY '20506064' | STEPHENS, REBECCA JOHANNA | — |
| Art Unit | Apps |
|---|---|
| 1663 | 15 |
| 3797 | 7 |
| 1662 | 7 |
| 3682 | 6 |
| 1672 | 6 |
| 1637 | 5 |
| 1636 | 5 |
| 1645 | 5 |
| 3795 | 5 |
| 1658 | 5 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19578246 | WHEAT VARIETY '25074375' | Gdm Argentina S.A. | SHARMA, SANTOSH | 1663 | §112 | Non-Final OA | — | Pending | Mar 25, 2026 |
| 19431636 | SYSTEMS AND METHODS FOR HIGHLY-PARALLEL TESTING WITH THERMAL CONTROL | Aem Singapore Pte. Ltd. | VELEZ, ROBERTO | 2858 | §102§103 | Final Rejection | — | Pending | Dec 23, 2025 |
| 19399542 | METHODS OF FORMING CIRCULARIZED RNA | Therorna Inc. | ANGELL, JON E | 1637 | §102§103§112 | Non-Final OA | — | Pending | Nov 24, 2025 |
| 19316329 | SYSTEMS AND METHODS FOR TRANSMISSION OF MEDICAL IMAGE METADATA | Stryker Corporation | DANG, HUNG Q | 2484 | §103 | Final Rejection | — | Pending | Sep 02, 2025 |
| 19288455 | MANAGEMENT AND COORDINATION OF DATA FOR DIGITAL THERAPEUTICS TRIALS | Click Therapeutics, Inc. | EZEWOKO, MICHAEL I | 3682 | §101§103 | Non-Final OA | — | Pending | Aug 01, 2025 |
| 19245212 | UNIFIED COMMUNICATION AND EQUIPMENT TRACKING MOBILE APPLICATION FOR MEDICAL ENVIRONMENTS | Stryker Corporation | GARTLAND, SCOTT D | 3683 | §101§103§112 | Non-Final OA | — | Pending | Jun 20, 2025 |
| 19240156 | OPERATING DEVICES IN AN OPERATING ROOM | Stryker Corporation | SOREY, ROBERT A | 3682 | §103 | Non-Final OA | — | Pending | Jun 17, 2025 |
| 19236768 | REJECTING SPURIOUS MAGNETIC FIELDS DURING MAGNETIC MARKER LOCALIZATION | Stryker Corporation | CELESTINE, NYROBI I | 3793 | §103 | Final Rejection | — | Pending | Jun 12, 2025 |
| 19231374 | DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY | Click Therapeutics, Inc. | LULTSCHIK, WILLIAM G | 3682 | §101§103 | Non-Final OA | 62d | Pending | Jun 06, 2025 |
| 19231379 | DIGITAL THERAPEUTIC METHOD AND SYSTEM EMPLOYING NUTRITIONAL COGNITIVE BEHAVIORAL THERAPY | Click Therapeutics, Inc. | GEBREMICHAEL, BRUK A | 3715 | §103 | Non-Final OA | 98d overdue | Pending | Jun 06, 2025 |
| 19227872 | SYSTEMS AND METHODS FOR 3D MODEL BASED DRONE FLIGHT PLANNING AND CONTROL | Neural Enterprises Inc. | BEAN, JARED C | 3669 | §103Other | Non-Final OA | — | Pending | Jun 04, 2025 |
| 19216652 | SYSTEMS AND METHODS FOR DETERMINING TIMING FOR FLUORESCENCE BASED BLOOD FLOW ASSESSMENT | Stryker Corporation | ALDARRAJI, ZAINAB MOHAMMED | 3797 | §102§103 | Non-Final OA | — | Pending | May 22, 2025 |
| 19215928 | SOYBEAN VARIETY '20506064' | Gdm Seeds Inc. | STEPHENS, REBECCA JOHANNA | 1663 | §112 | Non-Final OA | — | Pending | May 22, 2025 |
| 19216373 | ENGINEERING CASSAVA FOR IMPROVED GROWTH AND YIELD | National Chung Hsing University | KEOGH, MATTHEW R | 1663 | §102§103§112 | Non-Final OA | — | Pending | May 22, 2025 |
| 19216441 | NEIGHBORHOOD-GATED SWITCHING PIXEL SENSOR | Voxelsensors Srl | FOSSELMAN, JOEL W | 2639 | §102§103 | Non-Final OA | — | Pending | May 22, 2025 |
| 19210663 | MODIFYING THE SPECIFICITY OF PLANT NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION | Tropic Biosciences UK Limited | PAGE, BRENT T | 1663 | §101§102DP | Non-Final OA | — | Pending | May 16, 2025 |
| 19126628 | REMOVAL TOOL FOR MAGNETIC LOCALIZATION MARKER | Stryker Corporation | KLEIN, BROOKE L | 3797 | §103 | Final Rejection | — | Pending | May 01, 2025 |
| 19181163 | POLYPLOID HYBRID MAIZE BREEDING | Ohalo Genetics, Inc. | STEPHENS, REBECCA JOHANNA | 1663 | §112DP | Non-Final OA | — | Pending | Apr 16, 2025 |
| 19120634 | THERMAL COMPENSATION | Malvern Panalytical Limited | STAFIRA, MICHAEL PATRICK | 2877 | §102§103 | Non-Final OA | — | Pending | Apr 11, 2025 |
| 19173408 | SWISS CHARD VARIETY 'RHDF-611 23' | Pinnacle Seed, Inc. | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §112 | Non-Final OA | — | Pending | Apr 08, 2025 |
| 19092974 | SYSTEMS AND METHODS FOR MITIGATING ARTIFACTS IN MEDICAL IMAGING | Stryker Corporation | MONTOYA, OSCHTA I | 2421 | §102§103 | Final Rejection | — | Pending | Mar 27, 2025 |
| 19090231 | PLANT PROTEIN BASED IMITATION LEATHER FABRIC | Uncaged Innovations Inc. | IMANI, ELIZABETH MARY COLE | 1789 | §103 | Non-Final OA | — | Pending | Mar 25, 2025 |
| 19086929 | ENGINEERED RNA DEMETHYLASES FOR IMPROVED PLANT GROWTH | The University of Chicago | SHEN, YANXIN NMN | 1663 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2025 |
| 19085810 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | Tangram Therapeutics PLC | HUDSON, AMY ROSE | 1636 | §103 | Non-Final OA | 28d | Pending | Mar 20, 2025 |
| 19079832 | SYSTEMS AND METHODS FOR TRANSMITTING MEDICAL VIDEO DATA IN A BANDWIDTH CONSTRAINED ENVIRONMENT | Stryker Corporation | OCAK, ADIL | 2426 | §103 | Non-Final OA | — | Pending | Mar 14, 2025 |
| 19109411 | VISUAL ROBOTIC TASK CONFIGURATION SYSTEM | Tutor Intelligence, Inc. | LIN, ABBY YEE | 3657 | §103 | Non-Final OA | — | Pending | Mar 06, 2025 |
| 18722586 | LEATHER-LIKE BIOLOGICAL COMPOSITE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Institute Of Advanced Technology | ZHANG, MICHAEL N | 1784 | §112 | Non-Final OA | — | Pending | Feb 21, 2025 |
| 19055493 | COATINGS TO RESIST HIGH-TEMPERATURE OXIDATION IN A THERMAL ENERGY STORAGE SYSTEM | Exowatt, Inc. | TANENBAUM, TZVI SAMUEL | 3763 | §103§112 | Non-Final OA | — | Pending | Feb 17, 2025 |
| 19055495 | MODULAR- SEQUENTIAL- HIGH-TEMPERATURE HEAT COLLECTION AND STORAGE DEVICE WITH INTEGRATED POWER CONVERSION UNIT | Exowatt, Inc. | LARGI, MATTHEW THOMAS | 3746 | §102§103§112 | Final Rejection | 126d overdue | Pending | Feb 17, 2025 |
| 19054624 | POWER MODULATION FOR POWERING ONE OR MORE LIGHT SOURCES | Stryker Corporation | TRAN, MINH | 2845 | §103Other | Non-Final OA | — | Pending | Feb 14, 2025 |
| 19103139 | SUITCASE FRAME | Atr Brands Limited | TAMIL, JESSICA KAVINI | 3733 | §103§112 | Final Rejection | 16d | Pending | Feb 11, 2025 |
| 19046351 | ITERATIVE RAY-TRACING FOR AUTOSCALING OF OBLIQUE IONOGRAMS | Atmospheric & Space Technology Research Associates, L.L.C. | LEE, SARAH YEO | 2616 | Other | Non-Final OA | — | Pending | Feb 05, 2025 |
| 19039724 | CHAOTIC STORAGE OF PRESCRIPTION MEDICATIONS | Supporting Initiatives to Redistribute Unused Medicine (Sirum) | ALDERSON, ANNE-MARIE K | 3682 | §103 | Final Rejection | 28d overdue | Pending | Jan 28, 2025 |
| 18998440 | PARTICLE CHARACTERISATION | Malvern Panalytical Limited | LUU, THANH X | 2878 | §102§103 | Non-Final OA | — | Pending | Jan 24, 2025 |
| 19034403 | LIGHT ENGINE SYSTEMS AND METHODS FOR COMBINING LOW AND HIGH ETENDUE LIGHT | Stryker Corporation | BROOKS, JERRY L. | 2882 | §102§103 | Non-Final OA | — | Pending | Jan 22, 2025 |
| 19029911 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Cytokinetics, Inc. | FUBARA, BLESSING M | §112Other | Non-Final OA | — | Pending | Jan 17, 2025 | |
| 19021965 | SYSTEMS AND METHODS FOR UNDERWEAR FOR USE WITH LIMITED MOBILITY | Springrose, Inc. | NUNNERY, GRADY ALEXANDER | 3732 | §103 | Non-Final OA | 42d | Pending | Jan 15, 2025 |
| 19020993 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | Snipr Technologies Limited | GRASER, JENNIFER E | 1645 | §103DP | Non-Final OA | — | Pending | Jan 14, 2025 |
| 19007181 | METHODS AND SYSTEMS FOR NATURAL LANGUAGE PROCESSING OF GRAPH DATABASE QUERIES | The MITRE Corporation | HUANG, CHENG-FENG | 2497 | §103 | Non-Final OA | — | Pending | Dec 31, 2024 |
| 19002403 | SYSTEMS AND METHODS FOR IMAGE SEQUENCE REGISTRATION | Stryker Corporation | FUJITA, KATRINA R | 2672 | §102§103 | Non-Final OA | — | Pending | Dec 26, 2024 |
| 18988527 | ALZHEIMER'S DISEASE DIAGNOSIS METHOD AND DIAGNOSIS SYSTEM BASED ON NEURAL POPULATION SIGNAL SYNCHRONIZATION | Seoul National University R&Db Foundation | TOTH, KAREN E | 3791 | §101§103§112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18983728 | CANISTER WITH A PUMP FOR DISPERSING LIQUIDS AND METHOD OF USING THE SAME | Native Pet, Inc. | PANCHOLI, VISHAL J | 3754 | §103§112 | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18876111 | OPTICAL SENSING SYSTEM | Voxelsensors Srl | HULKA, JAMES R | 3645 | §102§103 | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18983117 | PIXEL SENSOR SYSTEM | Voxelsensors Srl | KO, TONY | 2878 | §102 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18873638 | IDENTIFICATION AND CHARACTERIZATION OF PANCREATIC CYSTIC LESIONS | BAYER AKTIENGESELLSCHAFT | VILLECCO, JOHN M | 2661 | §101§102 | Non-Final OA | — | Pending | Dec 10, 2024 |
| 18872752 | SUBSTITUTED PYRIDAZINE-3-CARBOXAMIDE COMPOUND SERVING AS TYK2 INHIBITOR | Guangzhou Fermion Technology Co., Ltd. | BELL, SARA ELIZABETH | 1625 | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18972633 | SOYBEAN VARIETIES | Asociados Don Mario S.A. | PAGE, BRENT T | 1663 | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18972620 | SOYBEAN VARIETIES '2984004', '2987413', AND '2987331' | Asociados Don Mario S.A. | PAGE, BRENT T | 1663 | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18969101 | MULTISPECIFIC POLYPEPTIDE CONSTRUCTS CONTAINING A CONSTRAINED CD3 BINDING DOMAIN AND A RECEPTOR BINDING REGION AND METHODS OF USING THE SAME | Inhibrx Biosciences, Inc. | CHEONG, CHEOM-GIL | 1645 | §103§112DP | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18968934 | METHODS AND SYSTEMS FOR MANAGING EXECUTION OF SURGICAL SOFTWARE APPLICATIONS | Stryker Corporation | HEBERT, THEODORE E | 2199 | §103 | Non-Final OA | — | Pending | Dec 04, 2024 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.4% of resolved applications prosecuted by Morrison & Foerster LLP were allowed, across 24,044 applications in USPTO records.
3.43 office actions per allowed application on average.
329 pending office actions as of October 2026, for 169 clients, before 297 examiners in 167 art units.
